Therapeutic strategies for acute intermittent porphyria

Acute intermittent porphyria (AIP) is an autosomal dominant disease caused by mutations in porphobilinogen deaminase (PBGD), the third enzyme of the heme synthesis pathway. Symptoms of AIP usually manifest as intermittent acute attacks with occasional neuropsychiatric crises. The management of AIP i...

Full description

Saved in:
Bibliographic Details
Published in:Intractable Rare Dis Res
Main Authors: Zhao, Lanlan, Wang, Xinyang, Zhang, Xiaoning, Liu, Xiantao, Ma, Ningzhen, Zhang, Yiran, Zhang, Songyun
Format: Artigo
Language:Inglês
Published: International Research and Cooperation Association for Bio & Socio-Sciences Advancement 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7586882/
https://ncbi.nlm.nih.gov/pubmed/33139979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2020.03089
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items